biote Corp.
BTMD
$3.47
$0.041.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 49.83M | 51.38M | 49.17M | 46.80M | 45.70M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 49.83M | 51.38M | 49.17M | 46.80M | 45.70M |
| Cost of Revenue | 14.30M | 15.17M | 15.29M | 13.37M | 14.01M |
| Gross Profit | 35.53M | 36.21M | 33.88M | 33.44M | 31.70M |
| SG&A Expenses | 30.30M | 23.15M | 24.92M | 23.01M | 24.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.60M | 38.32M | 40.21M | 36.38M | 38.37M |
| Operating Income | 5.23M | 13.06M | 8.96M | 10.43M | 7.34M |
| Income Before Tax | -1.22M | 15.86M | -10.30M | -3.32M | 9.33M |
| Income Tax Expenses | -4.70M | 3.20M | -11.00K | 2.49M | -2.74M |
| Earnings from Continuing Operations | 3.48M | 12.66M | -10.28M | -5.81M | 12.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 220.00K | -1.96M | 1.11M | 3.74M | -4.34M |
| Net Income | 3.70M | 10.70M | -9.18M | -2.07M | 7.73M |
| EBIT | 5.23M | 13.06M | 8.96M | 10.43M | 7.34M |
| EBITDA | 5.67M | 13.31M | 9.44M | 10.78M | 7.45M |
| EPS Basic | 0.12 | 0.34 | -0.28 | -0.06 | 0.23 |
| Normalized Basic EPS | 0.09 | 0.13 | 0.16 | 0.27 | -0.01 |
| EPS Diluted | 0.10 | 0.33 | -0.28 | -0.06 | 0.12 |
| Normalized Diluted EPS | 0.07 | 0.12 | 0.16 | 0.27 | 0.00 |
| Average Basic Shares Outstanding | 31.28M | 31.05M | 33.07M | 34.62M | 33.98M |
| Average Diluted Shares Outstanding | 37.29M | 32.26M | 33.07M | 34.62M | 63.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 4.23% | -44.89% | -4.01% | -- |